An important component of any regulation of tobacco products the FDA issues is an economic analysis of the regulation. Models of the health-related economic costs of cigarette smoking have evolved and improved over the years, and current models take into account the complex relationship between smoking, health, and healthcare expenditures. However, there is a lack of research on healthcare costs attributable to the use of tobacco products other than cigarettes. It is important to have this information given the increased rates at which non-cigarette products are being used. To fill this gap, we propose to develop models to estimate the healthcare costs (i.e. healthcare expenditures) resulting from the use of different tobacco products, including cigars, moist snuff, chewing tobacco, menthol and nonmenthol cigarettes, combinations of these products, and secondhand smoke exposure. Specifically, we plan to use individual level data from national surveys to 1) develop microeconomic models to estimate the healthcare costs attributable to the use of different tobacco products to determine whether the kind of product substantially affects costs and 2) develop microeconomic models to estimate the healthcare costs attributable to secondhand smoke exposure. These models will allow us to evaluate the impact of potential FDA regulations on healthcare costs through the projected changes in tobacco product use and secondhand smoke exposure using three alternative approaches (time senes analysis with data from national surveys, longitudinal model analysis with the PATH data, and simulated changes in tobacco product use prevalence) and through incorporating mathematical simulation models of short-term risks of pulmonary and cardiovascular diseases. Our models will incorporate findings from other TCORS projects, including the impact of nsk perception on use of different tobacco products among young adults and older adults, and studies ofthe effects of tobacco products on lung injury and cardiovascular disease in the short-term. Having better models ofthe cost of smoking and models of costs associated with the use of other tobacco products will be useful for the regulation of tobacco products because policy analysis needs to consider the impact of regulations on tobacco consumption as well as costs.

Public Health Relevance

We will develop, for the first time, estimates of the healthcare costs associated with the use of menthol cigarettes, cigars, moist snuff, and chewing tobacco as well as updated and improved estimates ofthe cost of cigarette smoking and secondhand smoke exposure. We will use an individual-level microeconomic cost model framework that improves upon the economic model used previously by the FDA. The models also can be used to evaluate the impact on healthcare expenditures of other policies that impact tobacco product use.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA180890-02
Application #
8754518
Study Section
Special Emphasis Panel (ZRG1-BDCN-A)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
2
Fiscal Year
2014
Total Cost
$513,942
Indirect Cost
$188,121
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Halpern-Felsher, Bonnie; Kim, Hyoshin (2018) Measuring E-cigarette use, dependence, and perceptions: Important principles and considerations to advance tobacco regulatory science. Addict Behav 79:201-202
Nabavizadeh, Pooneh; Liu, Jiangtao; Havel, Christopher M et al. (2018) Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke. Tob Control 27:s13-s19
Kulik, Margarete C; Lisha, Nadra E; Glantz, Stanton A (2018) E-cigarettes Associated With Depressed Smoking Cessation: A Cross-sectional Study of 28 European Union Countries. Am J Prev Med 54:603-609
Glantz, Stanton A; Gardiner, Philip (2018) Local Movement to Ban Menthol Tobacco Products as a Result of Federal Inaction. JAMA Intern Med 178:711-713
Barrington-Trimis, Jessica L; Gibson, Laura A; Halpern-Felsher, Bonnie et al. (2018) Type of E-Cigarette Device Used Among Adolescents and Young Adults: Findings From a Pooled Analysis of Eight Studies of 2166 Vapers. Nicotine Tob Res 20:271-274
Glantz, Stanton A; Bareham, David W (2018) E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications. Annu Rev Public Health 39:215-235
Yao, Tingting; Sung, Hai-Yen; Wang, Yingning et al. (2018) Healthcare costs attributable to secondhand smoke exposure at home for U.S. adults. Prev Med 108:41-46
McKelvey, Karma; Baiocchi, Mike; Ramamurthi, Divya et al. (2018) Youth say ads for flavored e-liquids are for them. Addict Behav :
St Helen, Gideon; Jacob Iii, Peyton; Nardone, Natalie et al. (2018) IQOS: examination of Philip Morris International's claim of reduced exposure. Tob Control 27:s30-s36
Moazed, Farzad; Chun, Lauren; Matthay, Michael A et al. (2018) Assessment of industry data on pulmonary and immunosuppressive effects of IQOS. Tob Control 27:s20-s25

Showing the most recent 10 out of 101 publications